SCHEMBL14257518

SCHEMBL14257518

CCCCOc1ccc(-c2nc(-c3ccc(OCCCC)cc3)nc(-c3ccc(OCCCC)cc3)n2)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.66
NPC1 O15118 5/20 0.66
SMN1; SMN2 Q16637 4/20 0.66
KDM4E B2RXH2 3/20 0.66
HSD17B10 Q99714 1/20 0.66
CYP2D6 P10635 12/20 0.63
CYP3A4 P08684 7/20 0.63
CYP2C9 P11712 10/20 0.62
CYP2C19 P33261 10/20 0.62
CYP19A1 P11511 10/20 0.62
MAPT P10636 2/20 0.58
HPGD P15428 2/20 0.58
ALDH1A1 P00352 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CYP1A2 P05177 7/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13539892 0.96 RAB9A (0.62) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL19601454 0.93 KDM4E (0.60) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL14330057 0.93 RAB9A (0.58) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL28131880 0.92 ACACB (0.61) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL28086856 0.90 RAB9A (0.60) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL12311572 0.89 RARB (0.56) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL1132424 0.88 LTA4H (0.60) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL28495475 0.87 RAB9A (0.57) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL8384771 0.86 RAB9A (0.64) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10
SCHEMBL12628222 0.85 MAPT (0.65) RAB9ANPC1SMN1; SMN2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103465538-B A kind of fenestrated membrane that adheres to glass pane outside LUCKY FILM CO., LTD. (CN) 2016-05-11 CN claimed
CN-103465538-A Window film adhered onto outer side of window glass LUCKY FILM CO LTD 2013-12-25 CN claimed
EP-3211056-B1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT OXFORD LTD (GB) 2020-07-22 EP disclosed
EP-2057249-B1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT OXFORD LTD (GB) 2017-11-08 EP disclosed
EP-3211056-A1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT Oxford Limited (GB) 2017-08-30 EP disclosed
US-9680110-B2 Compounds for use in opto-electrical devices CDT OXFORD LIMITED (GB) 2017-06-13 US disclosed
US-9680110-B2 Compounds for use in opto-electrical devices CDT OXFORD LIMITED (GB) 2017-06-13 US disclosed
CN-103465538-B A kind of fenestrated membrane that adheres to glass pane outside LUCKY FILM CO., LTD. (CN) 2016-05-11 CN disclosed
US-20150207081-A1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT OXFORD LIMITED (GB) 2015-07-23 US disclosed
US-20150207081-A1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT OXFORD LIMITED (GB) 2015-07-23 US disclosed
US-20150001509-A1 COMPOSITION CAMBRIDGE DISPLAY TECHNOLOGY, LTD (GB) 2015-01-01 US disclosed
US-20150001509-A1 COMPOSITION CAMBRIDGE DISPLAY TECHNOLOGY, LTD (GB) 2015-01-01 US disclosed
US-20140335638-A1 Compounds for Use in Opto-Electrical Devices CDT OXFORD LIMITED (GB) 2014-11-13 US disclosed
US-20140335638-A1 Compounds for Use in Opto-Electrical Devices CDT OXFORD LIMITED (GB) 2014-11-13 US disclosed
CN-103465538-A Window film adhered onto outer side of window glass LUCKY FILM CO LTD 2013-12-25 CN disclosed
WO-2008025997-A1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES CDT OXFORD LIMITED (GB) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150207081-A1 COMPOUNDS FOR USE IN OPTO-ELECTRICAL DEVICES TRPC5, PDE6C, TRPC6 RAB9A 3227/4885NPC1 4555/4885SMN1; SMN2 4157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.